We service over 700 Ophthalmologists with ImprimisRx compounded formulations prescribed for ophthalmic use.
Keep It Simple
Provide fewer drops at a lower cost with our proprietary topical ophthalmic compounded formulations* for patients following LASIK, PRK, cataract, and other ocular surgeries (and non-surgical applications).
Our formulations are enabled by our patented SSP Technology®, which allows active pharmaceutical ingredients (APIs) that ordinarily do not mix to solubilize into a predictable, well-distributed, micronized particle suspension.
Combination drop therapy® may reduce the number of eye drops needed after ocular surgery.
Commonly reported patient compliance issues after ocular surgery.1,2
- Daily dose frequency
- Inconsistent amount of drops used
- Instillation technique
- High cost to patients
Combination Drop Therapy Formulations
(Prednisolone acetate and gatifloxacin)
(Prednisolone acetate and nepafenac)
- PRED-GATI-BROMTM* or Triple DropTM
(Prednisolone acetate, gatifloxacin, bromfenac)
LessDrops Formulations from ImprimisRx
- Quality sterile compounded medications for pre and post ocular surgery
- Invented by ophthalmologists and pharmacists for unmet medical needs
- Patented Surfactant Solubilizing Process (SSP) technology® that uniquely allows for the combination of drugs
This approach alleviates the need for multiple postoperative drops and, in turn, helps cut medication costs. Developed with your patients top-of-mind, our proprietary topical compounded formulations aim to improve patient compliance and alleviate patient confusion with fewer drops, meaning they will be better able to follow the regimen you prescribe.